Intravenous anesthetics - An update;Update Intravenose Anasthetika

Anasthesiologie und Intensivmedizin

Volumn 37, Issue 9, 1996, Pages 449-456

  Lauven, P M ^a   Hellenthal, A ^a  

^a OWL University   (Germany)

Author keywords

analgetics, addictive; anesthetics; anesthetics, dissociative; pregnanolone

Indexed keywords

ALFENTANIL; DIAZEPAM; ELTANOLONE; ETOMIDATE; FENTANYL; KETAMINE; MIDAZOLAM; PROPOFOL; REMIFENTANIL; SUFENTANIL;

DRUG ACTIVITY; DRUG EFFECT; HUMAN; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; PHARMACOKINETICS; SHORT SURVEY;

EID: 0029738116     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (44)

1. Adams HA, Bauer R, Gebhardt B et al: Totale intravenöse Anästhesie mit S(+)-Ketamin in der orthopädischen Alterschirurgie. Anaesthesist 1994;43:92-100.
2. Ausems ME, Hug CC, Stanski DR et al: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 1986;65:362-373.
3. Bailie GR, Cockshott ID, Douglas EJ et al: Pharmacokinetics of propofol during and after long term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesth 1992,68:486-491.
4. Borgeat A, Wilder Smith OHG, Rifat K et al: Adjuvant propofol is effective in preventing refractory chemotherapy associated nausea and vomiting. Anesthesiology 1992;77:A344.
5. Borgeat A, Wilder Smith OHG, Saiah M et al: Subhypnotic doses of propofol possess antiemetic properties. Anesth Analg 1992;74:539-541.
6. Borgeat A, Wilder Smith OHG, Saiah M et al: Subhypnotic doses of propofol relieve pruritus induced by epidural and intrathecal morphine. Anesthesiology 1992;76:510-512.
7. Carl P, Hogskilde S, Nielsen JW et al: Pregnanolone Emulsion. Anesthesia 1990;45:189-197.
8. Carli F, Stribley GC, Clark MM: Forum: etomidate infusion in thoracic anaesthesia. Anaesthesia 1983;38:784-788.
9. Chilvers CR, Laurie PS: Successful use of propofol in status epilepticus. Anesthesia 1990;45:995-996.
10. Crozier TA, Beck D, Schlaeger M et al: Endocrinological changes following etomidate, midazolam, or methohexital for minor surgery. Anesthesiology 1987;66:628-635.
11. Dershwitz M, Randel GI, Rosow CE et al: Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995;81:619-623.
12. Doenicke A: Etomidat - Propofol. In: Rügheimer E (Hrsg): Konzepte zur Sicherheit in der Anästhesie. S. 57-70. Springer Berlin Heidelberg New York 1993.
13. Doenicke A, Kugler A, Vollmann N et al: Etomidat mit einem neuen Lösungsvermittler. Anaesthesist 1990; 39:475-480.
14. Eberle B: Vor- und Nachteile der Anwendung von Alfentanil/Sufentanil zur Narkoseeinleitung im Vergleich zu Fentanyl. In: Dick W et al (Hrsg): Totale Intravenöse Anästhesie.S.72-87. Springer Berlin Heidelberg New York 1993.
15. Egan TD, Lemmens HJM, Fiset P et al: The pharmacokinetics of the new short-acting opioid remifentanil in healthy adult male volunteers. Anesthesiology 1993;79:881-892.
16. Egan TD: Remifentanil pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1995;29:80-94.
17. Giese JL, Stockham RJ, Stanley TH et al: Etomidate versus thiopental for induction of anesthesia. Anesth Analg 1985;64:871-876.
18. Glass PSA: Prevention of awareness during total intravenous anesthesia. Anesthesiology 1993; 78:399-400.
19. Glass PSA: Remifentanil: A new opioid. J Clin Anesth 1995;7:558-563.
20. Gray HST, Holt BL, Whitaker DK et al: Preliminary study of a pregnanolone emulsion for i.v.induction of general-anaesthesia. Br J Anaesth 1992;68:272-276.
21. Hering W, Biburger G, Rügheimer E: Narkoseeinleitung mit dem neuen intravenösen Steroidanästhetikum Eltanolon (Pregnanolon). Anaesthesist 1993;42:74-80.
22. Hering W, Schlecht R, Geisslinger G et al: EEG analysis and pharmacodynamic modeling after intravenous bolus injection of eltanolone (pregnanolone). Europ J Anaesth 1995;12:407-415.
23. Hughes MA, Jacobs JR, Glass PSA: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthesia. Anesthesiology 1992;76:334-341.
24. Kallela H, Haasio J, Kortilla K: Comparison of eltanolone and propofol in anesthesia for termination of pregnancy. Anesth Analg 1994;79:512-516.
25. Kelly JS, Roy RC: Intraoperative awareness with propofol-oxygen total intravenous anesthesia for microlaryngeal surgery. Anesthesiology 1992;77:207-209.
26. Lauven PM, Röper A: Grundlagen der Pharmakokinetik. Anaesthesist 1995; 44:663-676.
27. Lauven PM, Schüttler J: Pharmakodynamik und Pharmakokinetik neuerer intravenöser Hypnotika. In: Dick W et al (Hrsg): Totale Intravenöse Anästhesie. S. 3-10. Springer Berlin Heidelberg New York 1993.
28. Laxenaire MC, Mata Bermejo E, Moneret Vautrin DA et al: Life-threatening anaphylactoid reactions to propofol. Anesthesiology 1992;77:275-280.
29. Ledingham IM, Finlay WIE, Watt I et al: Etomidate and adrenocortical function. Lancet 1983;I:1434.
30. Parke TJ, Stevens JE, Greenaway CL et al: Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992;305:613-616.
31. Powell H, Morgan M, Sear W: Pregnanolone: a new steroid intravenous anaesthetic. Anaesthesia 1992;47:287-290.
32. Rajah A, Powell H, Morgan M: Eltanolone for induction of anesthesia and to supplement nitrous oxide for minor gynaecological surgery. Anaesthesia 1993;48:951-954.
33. Scott JC, Ponganis KV, Stanski DR: EEG quantitation of narcotic effect. The comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 1985;62:234-241.
34. Scott JC, Cooke JE, Stanski DR: Electroencephalographic quantitation of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991;74:34-42.
35. Schüttler J: Pharmakokinetik und -dynamik des intravenösen Anaesthetikums Propofol (Disoprivan®. Springer Berlin Heidelberg 1990.
36. Schüttier J, Stoeckel H: Neue Opioide für die Anästhesie - Brauchen wir sie? Anästhesiol Intensivmed Notfallmed Schmerzther 1993;28:197-198.
37. Schüttler J, Stansky DR, White PF et al: Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokin Biopharm 1987;15:241-255.
38. Shafer A, Doze VA, Shafer SL et al: Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988;69:348-356.
39. Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991;74:53-63.
40. Sano T, Patel PM, Drummond JC et al: A comparison of the cerebral protective effects of etomidate, thiopental, and isoflurane in a model of forebrain ischemia in the rat. Anesth Analg 1993;76:990-997.
41. Van Hemelrijck J, Midier P, Van Aken H et al: Relative potency of eltanolone, propofol, and thiopental for induction of anesthesia. Anesthesiology 1994;80:36-41.
42. Veroli P, O'Kelly B, Bertrand F et al: Extrahepatic metabolism of propofol in man during anhepatic phase of orthotopic liver transplantation. Br J Anaesth 1992;68:183-186.
43. White PF, Ham J, Way WL et al: Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1980;52:231-239.
44. Wood PR, Browne GPR, Pugh S: Propofol infusion for the treatment of status epilepticus. Lancet 1988;I:480-481.